{
  "catalogId": "1f7d73ea-863c-497e-a51d-ecd150d60cfa",
  "name": "GLYXAMBI 25 MG/5 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "155 75 34509 00",
  "treatmentDescriptions": "GLYXAMBI tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate.  Limitations of UseGLYXAMBI is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.GLYXAMBI has not been studied in patients with a history of pancreatitis.  It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using GLYXAMBI.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "LINAGLIPTIN, EMPAGLIFLOZIN",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "A10BD19",
      "name": "LINAGLIPTIN AND EMPAGLIFLOZIN"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "GLYXAMBI 25 MG/5 MG 30 F.C.TAB",
      "manufacturer": {
        "name": "בורינגר אינגלהיים",
        "countryOfOrigin": "IL"
      },
      "strength": [
        {
          "value": 5.0,
          "unit": "mg"
        }
      ],
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/PVDC/ALUMINIUM",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "7820",
        "yarpa": "41770",
        "pharmasoft": "7935"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 263.6112893,
        "retailMargin": 17.5,
        "maxRetailPrice": 309.7432649,
        "maxPriceWithVAT": 365.4970364
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T16:49:25.945534",
    "tags": [],
    "smartValidation": {
      "extractedFrom": "GLYXAMBI 25 MG/5 MG 30 F.C.TAB",
      "processedBy": "smart_validation",
      "matchScore": 0.8250000000000001,
      "status": "corrected",
      "correctedAt": "2025-08-01T16:49:25.945549",
      "previousRegistration": "155 76 34531 00",
      "newRegistration": "155 75 34509 00",
      "apiSource": "GLYXAMBI 25 MG/5 MG"
    }
  },
  "nameHebrew": "גליקסמבי 25 מ\"ג /5 מ\"ג",
  "registrationDate": "2021-02-28"
}